888-969-2592
Kalkine 0
countryflagCA

Electrocore LLC

Healthcare US ECOR

5.2901USD
0.05(0.96%)

Last update at 2025-07-02T15:58:00Z

Day Range

5.215.44
LowHigh

52 Week Range

3.838.08
LowHigh

Fundamentals

  • Previous Close 5.24
  • Market Cap40.84M
  • Volume4555
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-15.41100M
  • Revenue TTM18.69M
  • Revenue Per Share TTM3.12
  • Gross Profit TTM 7.21M
  • Diluted EPS TTM-2.69

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -22.59300M -18.06930M -24.68200M -45.12900M -55.76302M
Minority interest - - 0.64M 0.64M 0.64M
Net income -22.16200M -17.21810M -23.51110M -45.14700M -55.82046M
Selling general administrative 24.33M 21.57M 0.02M 35.42M 42.50M
Selling and marketing expenses - - - - -
Gross profit 6.98M 4.07M 1.76M 1.23M 0.41M
Reconciled depreciation 0.55M 0.38M 0.40M 0.25M 0.07M
Ebit -23.42200M -20.04310M -24.28390M -44.09100M -53.89210M
Ebitda -22.87400M -22.01450M -23.81930M -42.09400M -53.82544M
Depreciation and amortization 0.55M -1.97140M 0.46M 2.00M 0.07M
Non operating income net other - - 0.07M 0.96M -1.20950M
Operating income -22.87400M -20.04310M -24.28390M -44.09100M -54.55352M
Other operating expenses 31.47M 25.49M 27.78M 46.48M 55.55M
Interest expense 0.29M 4.33M 0.46M 2.79M 0.00000M
Tax provision -0.43100M -0.85117M -1.17089M 0.02M 0.00243M
Interest income 0.29M 0.01M 0.08M 0.97M 1.01M
Net interest income 0.29M 0.01M 0.08M 0.97M 1.01M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.43100M -0.85120M -1.17090M 0.02M 0.00243M
Total revenue 8.59M 5.45M 3.50M 2.39M 0.99M
Total operating expenses 29.85M 24.11M 26.04M 45.32M 54.97M
Cost of revenue 1.62M 1.39M 1.74M 1.16M 0.58M
Total other income expense net 0.28M 1.97M -0.39810M -1.03800M -2.21583M
Discontinued operations - - - - -
Net income from continuing ops -22.16200M -17.21807M -23.51105M -45.14788M -55.76546M
Net income applicable to common shares -22.16200M -17.21807M -23.51105M -45.14788M -34.70212M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 16.39M 24.76M 42.83M 31.52M 36.10M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.84M 0.83M 1.05M 0.03M 1.09M
Total liab 8.95M 7.67M 6.18M 7.87M 10.56M
Total stockholder equity 7.44M 17.09M 36.65M 23.64M 24.90M
Deferred long term liab - - - - -
Other current liab 5.63M 4.69M 3.88M 2.80M 3.34M
Common stock 0.00600M 0.00500M 0.07M 0.05M 0.03M
Capital stock 0.00600M 0.00500M 0.07M 0.05M 0.03M
Retained earnings -165.20400M -146.37000M -124.20822M -106.99015M -83.47910M
Other liab - - - - 1.42M
Good will - - - - -
Other assets - 3.46M -0.00001M 4.89M 0.64M
Cash 10.58M 17.71M 34.69M 4.24M 13.56M
Cash and equivalents - - - - -
Total current liabilities 8.12M 7.04M 5.49M 5.89M 9.14M
Current deferred revenue 0.24M 0.15M - - -
Net debt -9.95500M -17.01300M -33.92803M -1.24784M -11.54580M
Short term debt 0.09M 0.07M 0.06M 1.01M 0.60M
Short long term debt - - - 0.48M 0.11M
Short long term debt total 0.63M 0.70M 0.76M 2.99M 2.02M
Other stockholder equity 172.70M 163.52M 160.77M 130.84M 108.39M
Property plant equipment - 0.61M 0.76M 0.24M 1.78M
Total current assets 14.29M 21.17M 37.54M 22.63M 26.53M
Long term investments - - - - -
Net tangible assets - 16.31M 36.13M 23.01M 23.18M
Short term investments - - 0.00000M 18.39M 10.50M
Net receivables 0.72M 0.40M 0.44M 0.27M 0.50M
Long term debt - - - 1.10M -
Inventory 2.16M 1.98M 1.36M 0.84M 0.89M
Accounts payable 2.16M 2.13M 1.54M 2.08M 5.21M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - 0.64M 0.64M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.06400M -0.06900M 0.01M -0.25147M -0.04129M
Additional paid in capital - - - - -
Common stock total equity - - - 0.05M 0.03M
Preferred stock total equity - - - - -
Retained earnings total equity - - - -106.99015M -83.47910M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 1.10M 2.97M 4.53M 8.13M 7.15M
Deferred long term asset charges - - - - -
Non current assets total 2.09M 3.58M 5.29M 8.89M 8.93M
Capital lease obligations 0.63M 0.70M 0.76M 1.42M 1.91M
Long term debt total - - - 1.10M -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 0.00000M 18.22M -7.96316M 51.04M -36.54891M
Change to liabilities 1.19M 0.46M -2.60459M 1.76M 2.91M
Total cashflows from investing activities - 18.22M -7.96316M 50.97M -36.82783M
Net borrowings - - 1.46M 0.11M 0.11M
Total cash from financing activities 0.00000M 25.68M 18.95M 0.16M 78.33M
Change to operating activities 0.52M 1.01M -1.18871M -0.17752M -0.36161M
Net income -22.16200M -17.21807M -23.51105M -45.14788M -55.76546M
Change in cash -16.72700M 30.45M -9.32185M 5.96M -5.62391M
Begin period cash flow 34.69M 4.24M 13.56M 7.60M 13.22M
End period cash flow 17.96M 34.69M 4.24M 13.56M 7.60M
Total cash from operating activities -16.64500M -13.62762M -20.10259M -45.06654M -47.11035M
Issuance of capital stock 0.00000M 25.68M 17.49M 0.00000M 78.33M
Depreciation 0.55M 0.38M 0.40M 0.25M 0.07M
Other cashflows from investing activities - - - 51.04M -36.54891M
Dividends paid - - - - 3629.09M
Change to inventory 0.30M 0.37M 0.74M -4.96177M -1.62162M
Change to account receivables 0.04M -0.21719M 0.23M -0.22854M -0.16439M
Sale purchase of stock - - - 0.05M 78.33M
Other cashflows from financing activities - 18.22M 2.56M 0.86M 3629.09M
Change to netincome 2.93M 1.58M 3.70M 3.97M 7.61M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.07M 0.28M
Change receivables - - 0.23M -0.22854M -0.16439M
Cash flows other operating - - 0.92M -0.18089M 0.35M
Exchange rate changes - - - - -0.02019M
Cash and cash equivalents changes - - -9.11388M 6.07M -5.62391M
Change in working capital 2.04M 1.63M -1.80906M -2.57010M -0.28909M
Stock based compensation 2.68M 3.30M 3.27M 3.90M 7.60M
Other non cash items 0.24M -0.01178M 0.53M -0.96382M -0.09562M
Free cash flow -16.64500M -13.62762M -20.10259M -45.13622M -47.38927M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ECOR
Electrocore LLC		 0.05 0.96% 5.29 - - 2.15 4.63 1.54 -1.3566
ABT
Abbott Laboratories		 -1.77 1.30% 134.49 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 -5.225 1.32% 391.51 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -0.1499 0.17% 88.60 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -1.14 1.09% 103.64 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Electrocore LLC

200 Forge Way, Rockaway, NJ, United States, 07866

Key Executives

Name Title Year Born
Mr. Daniel S. Goldberger CEO & Director 1959
Mr. Joseph P. Errico Co-Founder, Principal Investor & Director 1969
Dr. Thomas J. Errico M.D. Founder, Independent Director & Principal Investor 1952
Mr. Brian M. Posner CFO & Corp. Sec. 1962
Mr. Michael Romaniw Exec. VP of Systems & Operations 1957
Ms. Jackie Dorsky VP of Marketing NA
Mr. Iain Strickland Ph.D. Sr. VP of Global Sales & Strategy NA
Ms. Carrie Kochek Sr. Director of HR NA
Dr. Peter S. Staats M.B.A., M.D. Chief Medical Officer 1963
Mr. Eric J. Liebler Sr. VP of Neurology 1964

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.